The Lancet Respiratory Medicine in conversation with

Andrew Bush, Heather Zar, Fernando de Benedictis on how inhaled corticosteroids have changed the treatment of asthma Jun 15, 2026 805 Andrew Bush, Heather Zar, Fernando de Benedictis talk about their recent personal view piece where they summarise and discuss the 50-year journey and evolution of inhaled corticosteroids (ICS) in asthma treatment. Click here to read the full articles: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00082-2/abstract

Anne-Marie Dingemans; Isabelle Opiz; Corinne Faivre-Finn on a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability Mar 26, 2026 1705 Anne-Marie Dingemans, Isabelle Opiz, and Corinne Faivre-Finn talk about their multidisciplinary efforts to develop a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability. https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00051-2/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com

Anne Holland and Christine McDonald Mar 2, 2026 722 Anne Holland and Christine McDonald join Diana Stanley to discuss ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis. Click here to read the full article, Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): a randomised sham-controlled trial https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00005-6/fulltext Continue th

Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest Dec 22, 2025 472 Marion Moseby-Knappe talks about a prospective, international, observational biomarker study, within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial, to compare four markers of brain injury for the prediction of functional outcome in patients after cardiac arrest using assays that can be analysed on clinically available equipment. Click here to read t

Sailesh Kotecha on Prematurity-associated lung disease Nov 27, 2025 689 Prof Sailesh Kotecha joins Diana Stanley to discuss the series on reframing prematurity-associated lung disease as a continuum that begins before birth and evolves throughout life. Cick here to read the full series: Looking beyond bronchopulmonary dysplasia: prematurity-associated lung disease and its phenotypes https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00372-8/fulltext T

Neil Greening and Hnin Aung on Multidimensional prognostic risk stratification of COPD exacerbations Nov 25, 2025 925 Dr Neil Greening and Dr Hnin Aung join Diana Stanley to discuss a new multidimensional prognostic risk stratification model for COPD exacerbations. click here to read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00362-5/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup

Finn McQuaid and Matthew Saunders on Tuberculosis and Climate change Oct 30, 2025 650 Dr Finn McQuaid and Dr Matthew Saunders join Arianna Colosio to discuss an analytical framework to describe potential causal relationships between climate change and tuberculosis. Click here to read the full article Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://lin

Toby Maher on ENV-101 in patients with idiopathic pulmonary fibrosis Sep 28, 2025 566 Toby Maher joins us to discuss results of a randomised, double-blind, placebo-controlled, proof-of-concept trial of ENV-101, an oral inhibitor of the hedgehog signalling pathway, in patients with idiopathic pulmonary fibrosis. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00239-5/fulltext?dgcid=buzzsprout_icw_podcast_September_25_lanres Continue this con

Guy Brusselle and Celeste Porsbjerg on State-of-the-art insights into prevention, development, and management of asthma Sep 28, 2025 1363 Professors Guy Brusselle and Celeste Porsbjerg join us to discuss their recent Series papers on asthma, which will be featured in a cross journal project with The Lancet, published to coincide with a Lancet journal session on asthma at ERS in Amsterdam. The Series aims to provide an overview of recent research advances related to asthma; to provide new insights into the genetics, prevention and r

Joan Soriano on Global Epidemiology of Respiratory Disease Jul 17, 2025 631 Diana Stanley, Deputy Editor at The Lancet Respiratory Medicine, is joined by Dr Joan Soriano to discuss a new series on the global epidemiology of respiratory disease, exploring the diagnostic challenges, global trends, and future directions for prevention. Read the full Series: https://www.thelancet.com/series-do/global-epidemiology-chronic-respiratory-disease?dgcid=buzzsprout_icw_podcast_lanres

Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q trial Jul 16, 2025 1125 Carole Mitnick & Lorenzo Guglielmetti join Ari Colosio, deputy editor of The Lancet Respiratory Medicine, to discuss the ENDTB-Q trial to evaluate the efficacy and safety of a drug regiment to treat TB in individuals with pre-extensively drug-resistant tuberculosis. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00194-8/fulltext?dgcid=buzzsprout_icw_p

Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian) Jul 16, 2025 894 This episode is in Italian. For the English version, please see the main feed. Lorenzo Guglielmetti sul trial clinico ENDTB-Q per valutare l’efficacia e la sicurezza di un regime di farmaci per curare la tubercolosi in individui con tubercolosi pre-estesa farmaco-resistente. Leggi l'articolo completo: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00194-8/fulltext?dgcid=buzzspr

Laura Garriga-Grimau on bronchiectasis in children and young people Jul 2, 2025 730 Deputy editor Ari Colosio speaks with Dr. Laura Garriga-Grimau of the Val d’Hebron Hospital, Autonomous University of Barcelona. Dr. Garriga-Grimau discusses the first multi-country cohort study to describe the clinical features and standards of care for children and young people with bronchiectasis, drawing on data from the International Pediatric Bronchiectasis Registry. Together, they examine k

Marcus J Schultz and Prashant Nasa on defining and subphenotyping ARDS Jun 4, 2025 711 Bianca Brandon is joined by Professor Marcus Schultz and Dr Prashant Nasa to discuss their recent Position Paper reporting insights from an international Delphi expert panel on defining and subphenotyping ARDS. The findings underscore the need to refine the ARDS definition to better address heterogeneity of the condition and improve diagnostic precision, with use of subphenotyping where appropriat

Hjalmar Bouma on sepsis in patients who are immunocompromised May 20, 2025 813 Bianca Brandon, Senior Editor at The Lancet Respiratory Medicine, is joined by Professor Hjalmar Bouma to discuss a new review on sepsis in immunocompromised patients, exploring the diagnostic challenges, complexities of immune status, and future directions for targeted therapies. The episode also analyses the increased vulnerability of specific patient groups, the importance of biomarker-driven p

Simon Wolf on pulmonary embolism in children and adolescents in the US during 2016 and 2019 Apr 7, 2025 707 Deputy Editor of The Lancet Respiratory Medicine Ari Colosio discusses the critical findings of a new epidemiological study on pulmonary embolism in children and adolescents with Simon Wolf from the University Hospital of Zurich. This episode delves into the prevalence, risk factors, and clinical implications of this rare but serious condition, highlighting the need for increased awareness and fu

Sandeep Sahay and Franck Rahaghi on future treatment paradigms in pulmonary arterial hypertension Feb 19, 2025 893 Dr Sandeep Sahay and Professor Franck Rahaghi discuss their Personal View on future treatment paradigms in pulmonary arterial hypertension. Read the full paper, Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients, here: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00425-9/fulltext Continue this conve

Sergio Harari sul trattamento della linfangioleiomiomatosi (LAM) (in Italian) Oct 25, 2024 640 Il Professor Sergio Harari commenta i risultati di un trial clinico di fase 2 volto a valutare l’attivita’ e la sicurezza del farmaco nintedanib come trattamento in pazienti affetti da linfangioleiomiomatosi (LAM). Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://link

Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM) Oct 25, 2024 626 Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM). Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://you

Robert Kullberg on empirical antibiotics for Sepsis Oct 11, 2024 726 Dr Robert Kullberg joins us to discuss his Viewpoint on empiric antibiotic therapy for sepsis and the importance of reducing unnecessary use of anti-anaerobic antibiotics. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00257-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres Continue this conversation on social! Follow us today at... https://thelance

Heather Zar on early-life RSV disease and long-term respiratory health Sep 9, 2024 1147 Professor Heather Zar joins The Lancet Respiratory Medicine to discuss early-life RSV disease and long-term respiratory health. This topic will be covered in one of four Series papers in a cross-journal Series with The Lancet. You can read the Series of papers at: https://www.thelancet.com/series/respiratory-syncytial-virus?dgcid=buzzsprout_icw_podcast_generic Continue this conversation on social

Margaux Mesle on lives saved by COVID-19 vaccination Aug 7, 2024 621 Dr Margaux Mesle discusses estimates of lives directly saved by COVID-19 vaccination programs in the WHO European Region in the period from 2020 to 2023 and public health implications. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00179-6?dgcid=buzzsprout_icw_podcast_generic_lanres Continue this conversation on social! Follow us today at... https://thel

James Hull on protecting the respiratory health of athletes Jul 25, 2024 664 Professor James Hull joins us to discuss his recent Spotlight on protecting the respiratory health of athletes ahead of the Summer Olympics and Paralympics. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00183-8?dgcid=buzzsprout_icw_podcast_generic_lanres Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://i

Eric Lim on treatments for pleural mesothelioma May 10, 2024 377 Professor Eric Lim discusses the outcomes after extended pleurectomy decortication plus chemotherapy versus chemotherapy alone for pleural mesothelioma. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Anne Chang on the burden of chronic respiratory diseases in Indigenous people Apr 24, 2024 589 Dr Anne Chang discusses the burden of chronic respiratory diseases in Indigenous people. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00008-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetm

Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC Mar 12, 2024 623 Professor Daniel Steinfort and Professor Shankar Siva discuss the effect of systematic endoscopic mediastinal staging on radiotherapy field planning in patients with locally advanced non-small-cell lung cancer. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn

Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID Jan 16, 2024 496 Prof Daniel Prieto-Alhambra, Dr Annika Jödicke, and Dr Martí Català discuss the effectiveness of COVID-19 vaccines to prevent Long COVID, estimated to affect up to 20% of those infected with SARS-CoV-2. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00414-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres Continue this conversation on social! Follow

Sarah Gorst and Tim Nicholson on long COVID outcomes Nov 2, 2023 932 Dr Tim Nicholson and Dr Sarah Gorst discuss the development of an international Delphi consensus study on a core outcome measurement set for long COVID and how it will be used to inform future research and clinical care. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https:

Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19 Oct 4, 2023 722 Dr Betty Raman discusses multiorgan MRI findings in patients after hospitalisation with COVID-19. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00262-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/t

Keith Chappell on a bivalent recombinant vaccine for COVID-19 Sep 13, 2023 493 Dr Keith Chappell discusses the bivalent recombinant vaccine for COVID-19 following the study by Dayan and colleagues, with focus on vaccine access, variants and boosters, tolerability and side effects, as well as hopes for future trials. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmed

James Chalmers on bronchiectasis across Europe Apr 26, 2023 717 Prof. James Chalmers discusses the characteristics of patients with bronchiectasis across Europe, the differences between countries, and possible differences in clinical outcomes, based on data from the EMBARC registry. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00093-0/fulltext?dgcid=buzzsprout_tlv_episode-notes_general_general Continue this convers

Richard Costello on management of uncontrolled asthma Mar 21, 2023 698 Prof Richard Costello discusses the use of digital measurements of medication adherence and lung function to guide management of uncontrolled asthma. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Keiju Aokage on segmentectomy for ground-glass-dominant lung cancer Mar 6, 2023 351 Dr Keiju Aokage discusses segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less. Read the full article: Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial Continue this conversation on social! Follow us today at... https://t

Carol Hodgson on post-discharge outcomes for ECMO patients Feb 9, 2023 1156 Carol Hodgson discusses recent advances in our understanding of in-hospital and post-discharge outcomes in critically ill patients who receive ECMO. Read the full article: Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES) Continue this conversation on social! Follow us tod

Emma Grainger on 10 years of The Lancet Respiratory Medicine Dec 22, 2022 786 Emma Grainger, Editor-in-Chief of The Lancet Respiratory Medicine, discusses the January issue and plans to celebrate the 10-year anniversary of the journal. Read the Editorial from the 10th anniversary issue: Past learnings and new beginnings in the digital age Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https:/

Vivienne Kahlmann and Catharina Moor on the TIRED study Nov 23, 2022 540 Vivienne Kahlmann and Catharina Moor discuss a study looking at online mindfulness-based cognitive behaviour treatment to address fatigue associated with sarcoidosis. Read the full article: Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED) Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/the

Yves Lacasse on long-term oxygen therapy for COPD Jul 31, 2022 1035 Yves Lacasse joins The Lancet Respiratory Medicine to discuss a meta-analysis on the effectiveness of home oxygen use for patients with COPD. Read the full article: Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thela

Rachael Evans on living with long COVID Jul 26, 2022 808 Rachael Evans discusses the needs of people with long COVID and the latest findings from the PHOSP-COVID study. Read the full article: Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID) Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljour

Daniel Munblit and Dale Needham on core outcomes post-COVID-19 Jun 15, 2022 997 Daniel Munblit and Dale Needham discuss the importance of developing a core outcome set for post-COVID-19 condition. Read the full Position Paper: A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com

Daiana Stolz on antibiotic stewardship in pneumonia May 24, 2022 616 Daiana Stolz discusses antibiotic stewardship in patients hospitalised with pneumonia and at risk of Gram-negative bacterial infection. Read the full article: Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II) Continue this conversation on social! Follow us today at..

Ablo Wachinou on sleep disordered breathing in Benin Apr 8, 2022 639 Dr Ablo Wachinou discusses the prevalence of sleep disordered breathing in Benin and how awareness and treatment might be improved. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID Apr 7, 2022 886 Professor Peter Openshaw and Dr Felicity Liew discuss the use of inhaled corticosteroids in the early treatment of COVID and the involvement of the respiratory mucosa in response to viral infection. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/compan

Dinh Bui on preterm birth and lung function deficits Feb 18, 2022 331 Dr Dinh Bui discusses the association between very-to-moderate preterm birth and lung function deficits and COPD at age 53. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Ruvim Izĭckson on a joint flu and COVID-19 vaccine Jan 31, 2022 521 Ruvim Izĭckson discusses the safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine together with a third dose of the Moderna COVID-19 vaccine in adults aged 65 years and older. Read the full article: Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged

Wisia Wedzicha on a vaccine for COPD Jan 11, 2022 545 Wisia Wedzicha discusses findings of a trial of a vaccine for the prevention of COPD exacerbations and provides her insights for future research. Read the full article: Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease Continue this conversation on social! Follow us today at... https://thelancet.bsky.soci

Eileen Rubin on patient-centered ARDS Dec 30, 2021 1025 Eileen Rubin, author of a paper on advancing precision medicine for acute respiratory distress syndrome discusses her delayed diagnosis and how clinician and researcher goals can differ from those of patients. Read the full article: Advancing precision medicine for acute respiratory distress syndrome Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https:

Daniel Altmann on COVID boosters Nov 30, 2021 971 Daniel Atlmann discusses the duration of immune protection from COVID vaccination and the crucial implications for the implementation of booster vaccination programmes. Read the full article: Waning immunity to SARS-CoV-2: implications for vaccine booster strategies - The Lancet Respiratory Medicine Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https:

Michael Kreuter on interstitial lung disease Sep 6, 2021 508 Comment author Michael Kreuter discusses a series of papers published in The Lancet and The Lancet Respiratory Medicine on interstitial lung disease. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00403-3/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebo

Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19 Aug 20, 2021 724 Bairbre McNicholas and Jie Li discuss an open label superiority meta-trial looking at the efficacy of awake prone positioning for patients with COVID-19 acute hypoxaemic respiratory failure. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00356-8/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https:/

Charles Sprung and authors on end-of-life practices in ICUs globally Aug 3, 2021 941 Charles Sprung and fellow co authors Christiane Hartog, Joseph Nates, and Gavin Joynt discuss the Ethicus-II study, which looked at differences in end-of-life care in nearly 200 ICUs across 36 countries. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00261-7/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.socia

Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma Jul 10, 2021 797 Christopher Brightling discusses the effect of blocking thymic stromal lymphopoietin (TSLP) with tezepelumab in patients with moderate-to-severe uncontrolled asthma. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00226-5/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgrou

Paul Verweij on COVID-19 associated aspergillosis May 26, 2021 396 Dr. Paul Verweij discusses a Personal View published in TLRM on COVID-19 associated aspergillosis. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00138-7/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com

Ignacio Rubio on COVID-19 pathophysiology and phenotypes May 17, 2021 559 Dr. Ignacio Rubio discusses a comprehensive review of the pathophysiology and phenotypes of COVID-19, the first in a Series of four papers about the pathophysiology of acute disease. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00218-6/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.

Kiran Shekar on cytokine adsorption and severe COVID-19 pneumonia May 14, 2021 594 Dr. Kiran Shekar discusses a randomized controlled trial looking at cytokine adsorption in patients with severe COVID-19 pneumonia. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00207-1/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetme

Fan Chung on chronic cough and long COVID May 11, 2021 692 Dr Fan Chung discuses confronting COVID-19-associated cough and the post-COVID syndrome. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00125-9/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/t

Mepolizumab and the treatment of chronic rhinosinusitis Apr 16, 2021 438 Dr. Joseph Han discusses the results of the phase III SYNAPSE trial, evaluating the efficacy and safety of mepolizumab in patients with chronic rhinosinusitis. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00097-7/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup http

Inhaled budesonide in the treatment of early COVID-19 Apr 15, 2021 624 Dr. Mona Bafadhel discusses the STOIC trial, which looked at the use of inhaled budesonide in the treatment of early COVID-19. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00160-0/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedical

Tocilizumab and COVID-19 Mar 5, 2021 345 Dr. Arvinder Soin discusses the use of tocilizumab plus standard care versus standard care alone in the treatment of moderate to severe COVID-19-associated cytokine release syndrome. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00081-3/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram

Interferon treatment and COVID-19 Feb 6, 2021 394 Jordan Feld discusses the use of peginterferon-lambda in the treatment of ambulatory COVID-19 patients. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30566-X/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedI

Evaluating deterioration in patients with acute COVID-19 Jan 12, 2021 509 Rishi Gupta discusses a model to evaluate and predict the risk of clinical deterioration in patients with acute COVID-19. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30559-2/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljourn

Treatment options in patients with systemic sclerosis-associated interstitial lung disease Jan 5, 2021 945 Toby Maher discusses the results of the SENSCIS trial, looking at the safety and efficacy of nintedanib in systemic sclerosis-associated interstitial lung disease (SSc-ILD) treated with mycophenolate. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30458-6/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/

COVID-19 and severe influenza Dec 18, 2020 488 Dr. Catherine Quantin discusses a new study looking at the ways severe influenza and COVID-19 are similar and differ. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

The second wave and homeless populations Nov 11, 2020 477 Dan Lewer of University College London discusses a modelling study that looks at housing strategies for homeless populations in the UK during COVID-19. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

The Lancet Respiratory Medicine in conversation with

Episodes

Recommended